HuGE Literature Finder
Records
1
-
30
| Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial. Gynecologic oncology 2021 Nov . Hodgson Darren R, Brown Jessica S, Dearden Simon P, Lai Zhongwu, Elks Cathy E, Milenkova Tsveta, Dougherty Brian A, Lanchbury Jerry S, Perry Michael, Timms Kirsten M, Harrington Elizabeth A, Barrett J Carl, Leary Alexandra, Pujade-Lauraine Er |
| Impact of BRCA mutations and hormone receptor status on reproductive potential in breast cancer patients undergoing fertility preservation. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2021 Nov 1-4. Kim Sung Woo, Kim Tae Hee, Han Ji Yeon, Kim Seul Ki, Lee Jung Ryeol, Jee Ung Chul, Suh Chang Suk, Kim Seok Hy |
| Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness. NPJ breast cancer 2021 Nov 7 (1): 142. Metzger-Filho Otto, Collier Katharine, Asad Sarah, Ansell Peter J, Watson Mark, Bae Junu, Cherian Mathew, O'Shaughnessy Joyce, Untch Michael, Rugo Hope S, Huober Jens B, Golshan Mehra, Sikov William M, von Minckwitz Gunter, Rastogi Priya, Li Lang, Cheng Lijun, Maag David, Wolmark Norman, Denkert Carsten, Symmans W Fraser, Geyer Charles E, Loibl Sibylle, Stover Daniel |
| Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer. British journal of cancer 2021 Oct . Guzmán-Arocho Yaileen D, Rosenberg Shoshana M, Garber Judy E, Vardeh Hilde, Poorvu Philip D, Ruddy Kathryn J, Kirkner Gregory, Snow Craig, Tamimi Rulla M, Peppercorn Jeffrey, Schapira Lidia, Borges Virginia F, Come Steven E, Brachtel Elena F, Marotti Jonathan D, Warner Ellen, Partridge Ann H, Collins Laura |
| Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center. Annals of surgical oncology 2021 Oct . Mittal Abhenil, Deo S V S, Gogia Ajay, Batra Atul, Kumar Akash, Bhoriwal Sandeep, Deb Koushik Sinha, Dhamija Ekta, Thulkar Sanjay, Ramprasad V L, Olopade Olufunmilayo, Pramanik Ra |
| Association of RAD51 with Homologous Recombination Deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial. Annals of oncology : official journal of the European Society for Medical Oncology 2021 Sep . Llop-Guevara A, Loibl S, Villacampa G, Vladimirova V, Schneeweiss A, Karn T, Zahm D-M, Herencia-Ropero A, Jank P, van Mackelenbergh M, Fasching P A, Marmé F, Stickeler E, Schem C, Dienstmann R, Florian S, Nekljudova V, Balmaña J, Hahnen E, Denkert C, Serra |
| Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study. Breast cancer (Tokyo, Japan) 2021 Sep . Koh Su-Jin, Ohsumi Shozo, Takahashi Masato, Fukuma Eisuke, Jung Kyung Hae, Ishida Takanori, Dai Ming-Shen, Chang Chuan-Hsun, Dalvi Tapashi, Walker Graham, Bennett James, O'Shaughnessy Joyce, Balmaña Judi |
| Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 2021 Sep 60 155-162. Gasparri Maria Luisa, Di Micco Rosa, Zuber Veronica, Taghavi Katayoun, Bianchini Giampaolo, Bellaminutti Serena, Meani Francesco, Graffeo Rossella, Candiani Massimo, Mueller Michael D, Papadia Andrea, Gentilini Oreste |
| PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer. Anti-cancer drugs 2021 Sep . Rose Peter G, Yao Meng, Chambers Laura M, Mahdi Haider, DeBernardo Robert, Michener Chad M, AlHilli Miriam, Ricci Stephanie, Vargas Rober |
| The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis. Cancer cell international 2021 Sep 21 (1): 474. Moslemi Masoumeh, Vafaei Maryam, Khani Pouria, Soheili Marzieh, Nedaeinia Reza, Manian Mostafa, Moradi Yousef, Sohrabi Ehs |
| Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes. Cancer 2021 Aug . Momtaz Parisa, O'Connor Catherine A, Chou Joanne F, Capanu Marinela, Park Wungki, Bandlamudi Chaitanya, Berger Michael F, Kelsen David P, Suehnholz Sarah P, Chakravarty Debyani, Yu Kenneth H, Varghese Anna M, Zervoudakis Alice, Li Jia, Ku Geoffrey Y, Park Jennifer S, Shcherba Marina, Harding James J, Goldberg Zoe, Abou-Alfa Ghassan K, Salo-Mullen Erin E, Stadler Zsofia K, Iacobuzio-Donahue Christine A, O'Reilly Eileen |
| Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. British journal of cancer 2021 Aug . Jørgensen Nanna, Hviid Thomas Vauvert F, Nielsen Lise B, Sønderstrup Ida M H, Eriksen Jens Ole, Ejlertsen Bent, Gerdes Anne-Marie, Kruse Torben A, Thomassen Mads, Jensen Maj-Britt, Lænkholm Anne-Vibe |
| Venous thromboembolism incidence in cancer patients with germline BRCA mutations. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 Aug . Muñoz A J, de Toro M, Ortega L, López C, Gutiérrez A, Juliao D S, Arregui M, Lobato N, Echavarría I, Márquez-Rodas I, Martín |
| Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021 Aug . Kim Shana J, Lubi?ski Jan, Huzarski Tomasz, Møller Pål, Armel Susan, Karlan Beth Y, Senter Leigha, Eisen Andrea, Foulkes William D, Singer Christian F, Tung Nadine, Bordeleau Louise, Neuhausen Susan L, Olopade Olufunmilayo I, Eng Charis, Weitzel Jeffrey N, Fruscio Robert, Narod Steven A, Kotsopoulos Joan |
| OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis. European journal of cancer (Oxford, England : 1990) 2021 Jul 154 209-216. Davey Matthew G, Richard Vinitha, Lowery Aoife J, Kerin Michael |
| Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan. Scientific reports 2021 Jul 11 (1): 14906. Abdel-Razeq Hikmat, Abujamous Lama, Abunasser Mahmoud, Edaily Sara, Bater Ray |
| Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers - an Israeli matched pair study. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2021 Jul . Perri Tamar, Levin Gabriel, Naor-Revel Shani, Eliassi-Revivo Perry, Lifshitz Dror, Friedman Eitan, Korach Jac |
| A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2. Molecular biology reports 2021 Jun . Sahin Ibrahim, Saat Hani |
| Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study. Gynecologic oncology 2021 Jun . Safra Tamar, Waissengrin Barliz, Gerber Deanna, Bernstein-Molho Rinat, Klorin Geula, Salman Lina, Josephy Dana, Chen-Shtoyerman Rakefet, Bruchim Ilan, Frey Melissa K, Pothuri Bhavana, Muggia Fran |
| Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. NPJ breast cancer 2021 Jun 7 (1): 76. Li Na, Lim Belle W X, Thompson Ella R, McInerny Simone, Zethoven Magnus, Cheasley Dane, Rowley Simone M, Wong-Brown Michelle W, Devereux Lisa, Gorringe Kylie L, Sloan Erica K, Trainer Alison, Scott Rodney J, James Paul A, Campbell Ian |
| Malignant salivary gland tumours in families with breast cancer susceptibility. Virchows Archiv : an international journal of pathology 2021 Jun . Ripamonti Carla B, Bossi Paolo, Manoukian Siranoush, Locati Laura, Colombo Mara, Carcangiu Maria L, Vingiani Andrea, Licitra Lisa, Radice Pao |
| Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study. JCO global oncology 2021 Jun 7 849-861. Gupta Sudeep, Rajappa Senthil, Advani Suresh, Agarwal Amit, Aggarwal Shyam, Goswami Chanchal, Palanki Satya Dattatreya, Arya Devavrat, Patil Shekhar, Kodagali Roh |
| RASSF1A Suppression as a Potential Regulator of Mechano-Pathobiology Associated with Mammographic Density in BRCA Mutation Carriers. Cancers 2021 Jun 13 (13): . Reye Gina, Huang Xuan, Britt Kara L, Meinert Christoph, Blick Tony, Xu Yannan, Momot Konstantin I, Lloyd Thomas, Northey Jason J, Thompson Erik W, Hugo Honor |
| Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer. Journal of personalized medicine 2021 Jun 11 (7): . Bekos Christine, Grimm Christoph, Kranawetter Marlene, Polterauer Stephan, Oberndorfer Felicitas, Tan Yen, Müllauer Leonhard, Singer Christian |
| Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next? International journal of molecular sciences 2021 May 22 (11): . Zuntini Roberta, Bonora Elena, Pradella Laura Maria, Amato Laura Benedetta, Vidone Michele, De Fanti Sara, Catucci Irene, Cortesi Laura, Medici Veronica, Ferrari Simona, Gasparre Giuseppe, Peterlongo Paolo, Sazzini Marco, Turchetti Danie |
| NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer. Scientific reports 2021 May 11 (1): 11125. Marchetti Claudia, D'Indinosante Marco, Bottoni Carolina, Di Ilio Chiara, Di Berardino Stefano, Costantini Barbara, Minucci Angelo, Vertechy Laura, Scambia Giovanni, Fagotti An |
| Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina. Cancers 2021 May 13 (11): . Solano Angela R, Mele Pablo G, Jalil Fernanda S, Liria Natalia C, Podesta Ernesto J, Gutiérrez Leandro |
| Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature. Gynecologic oncology 2021 Apr . Giannone G, Scotto G, Katsaros D, De Giorgi U, Farolfi A, Borella F, Cosma S, Ferrero A, Mangiacotti S, Villa M, Tuninetti V, Ghisoni E, Turinetto M, Mittica G, Gemmiti S, Zavallone L, Aglietta M, Pasini B, Di Maio M, Valabrega |
| Beyond BRCA Status: Clinical Biomarkers May Predict Therapeutic Effects of Olaparib in Platinum-Sensitive Ovarian Cancer Recurrence. Frontiers in oncology 2021 11 697952. Nakanishi Kazuho, Yamada Takashi, Ishikawa Gen, Suzuki Shun |
| Germline and Somatic mutations in postmenopausal breast cancer patients. Clinics (Sao Paulo, Brazil) 2021 76 e2837. Nagy Tauana Rodrigues, Maistro Simone, Encinas Giselly, Katayama Maria Lucia Hirata, Pereira Glaucia Fernanda de Lima, Gaburo-Júnior Nelson, Franco Lucas Augusto Moyses, Gouvêa Ana Carolina Ribeiro Chaves de, Diz Maria Del Pilar Estevez, Leite Luiz Antonio Senna, Folgueira Maria Aparecida Azevedo Koi |
- Page last reviewed:Oct 1, 2021
- Page last updated:Nov 23, 2021
- Content source: